Biotech grants

Between cycles

Funds Georgia-based small businesses hiring a grant writing consultant to prepare a competitive SBIR or STTR application.

Between cycles

Provides Australia innovators with hands-on guidance for commercialization strategy and growth planning and commercialization planning.

Between cycles

Funds mission-driven founders in health, technology, and social enterprises through philanthropic grant-like programs targeting impact.

Between cycles

Funds qualifying New York ventures with tax-based capital support for economic development and growth-stage expansion.

Between cycles

Offers sector-focused tax credits in Pennsylvania for semiconductor, biomedical, food processing, chemicals, and clean hydrogen manufacturing.

Closed

Invests in early-career researchers transitioning to independent research leadership across all scientific fields.

Closed

Funds preclinical translational partnerships for companies advancing Friedreich ataxia therapies.

Closed

Supports United Kingdom large-team bioscience projects through collaborative grants for high-impact innovation.

Closed

Funds organizations conducting clinical trials of vaccine candidates against CEPI priority pathogens and viral families through CEPI's Innovations Call for Proposals.

Closed

Funds NIH-eligible teams refining and testing point-of-care cancer diagnostics through six- or twelve-month subawards.

Closed

Funds U.S. small businesses and their research institution partners conducting early-stage space technology R&D through NASA's Small Business Technology Transfer program.

Closed

Funds Stanford teams piloting and advancing validated health innovations through capital and hands-on operating support.

Closed

Pays up to 25 small consortia EUR 200,000 each to test the commercial exploitation potential of results that already came out of earlier Horizon Europe or Horizon 2020 Cluster 4 projects.

Closed

Pays teams up to $10,000 each, plus six months of biotech mentoring, for drug-use research ideas.

Closed

Awards up to $75,000 and a 5-month accelerator to entrepreneurs building aging-research startups.

Closed

Supports Taiwan researchers with structured pathways in early-career academic excellence awards, from planning to deployment.

Closed

Funds lead optimization and in vivo testing for frontotemporal dementia candidates, including medicinal chemistry and preclinical studies.

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

Closed

Funds organizations worldwide improving women’s health through integrated mental and physical wellbeing initiatives.

Closed

Pays deep-tech start-ups, SMEs and research organisations a €300,000 lump sum in Stage 1, then up to €2.5 million in Stage 2, to push high-risk breakthrough innovations that lack commercial uptake toward real-world, demand-tested deployment.

Closed

Funds advanced postdoctoral researchers with substantial support to strengthen independent study in type 1 diabetes science.

Closed

Funds early clinical trials of therapies built from the molecules cells secrete rather than the cells themselves, aiming for an off-the-shelf alternative to cell therapy.

Closed

Funds Texas A&M teams translating early discoveries through commercialization support and enterprise readiness.

Pays up to $7,000 in cash, plus a fully paid trip to Seoul, to anyone with an idea that reduces or replaces animal testing.